By using a similar approach, the same group developed cGAMP-loaded vEVs (cGAMP@vEVs), which synergistically activated the STING pathway in lymph nodes and reprogrammed the tumor microenvironment (TME). The gene discussed is STING1; the disease is neoplasm.